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Epidemiological studies report a negative association between circulating bilirubin concentra-
tions and the risk for cancer and cardiovascular disease. Structurally related tetrapyrroles also
possess in vitro anti-genotoxic activity and may prevent mutation prior to malignancy.
Furthermore, few data suggest that tetrapyrroles exert anti-carcinogenic effects via induction
of cell cycle arrest and apoptosis. To further investigate whether tetrapyrroles provoke DNA-
damage in human cancer cells, they were tested in the single cell gel electrophoresis assay
(SCGE). Eight tetrapyrroles (unconjugated bilirubin, bilirubin ditaurate, biliverdin, biliverdin-/
bilirubin dimethyl ester, urobilin, stercobilin and protoporphyrin) were added to cultured Caco2
and HepG2 cells and their effects on comet formation (% tail DNA) were assessed. Flow
cytometric assessment (apoptosis/necrosis, cell cycle, intracellular radical species generation)
assisted in revealing underlying mechanisms of intracellular action. Cells were incubated with
tetrapyrroles at concentrations of 0.5, 5 and 17 mM for 24 h. Addition of 300 mM tertiary-butyl
hydroperoxide to cells served as a positive control. Tetrapyrrole incubation mostly resulted in
increased DNA-damage (comet formation) in Caco2 and HepG2 cells. Tetrapyrroles that are
concentrated within the intestine, including protoporphyrin, urobilin and stercobilin, led to
signiﬁcant comet formation in both cell lines, implicating the compounds in inducing DNA-
damage and apoptosis in cancer cells found within organs of the digestive system.
& 2012 Elsevier Inc. Open access under CC BY-NC-ND license. Introduction
Bile pigments (BPs) such as bilirubin (BR), biliverdin (BV) and
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within certain organs including the liver and intestine. Tetra-
pyrroles derived from this process are found in the bile (mainly
conjugated BR), and in the intestinal milieu (mainly stercobilin
SB, urobilin UB and protoporphyrin PRO) [2,3]. The literature
reports anti-mutagenic, antioxidant as well as potentially anti-
carcinogenic activities of BR and BV in vitro [4–8]. Further
studies suggest an important role for mildly elevated circulating
BR in preventing disease in human subjects [9–13] by antio
idant mechanisms [9,11–13], and emphasize a protective phy-
siological role for unconjugated BR in protecting against gastro-
intestinal and colorectal cancers [14]. These effects might also
be related to BR’s intestinal abundance [14], with recent
evidence indicating the potential efﬁcacy of intestinal absorp-
tion [15,16]. Consequently, physiologically abundant TPs could
play signiﬁcant health promoting roles in the organs where they
are absorbed/accumulated including the liver, gall bladder and
intestine [17] in addition to the urinary tract and the circulatory
system [16].
Thus far, the scientiﬁc focus has mainly been directed toward
in vitro anti-genotoxic properties of BR and BV [5,18], with little
attention focused on structurally related metabolites. Unconjugated
BR induces cell cycle arrest, apoptosis and cytostasis in vitro in
multiple cell lines [19]. Besides, BR may be defending against
cancer by interfering with pro-carcinogenic signaling pathways,
and therefore potently inhibit tumor cell proliferation in vivo [19].
Furthermore, BR induces mitochondrial depolarization in colon
cancer cells, as it diffuses across the outer mitochondrial mem-
brane, and thereby activates the intrinsic apoptotic pathway [17].
However, data concerning the effects of related tetrapyrrolic
compounds on cancer cell biology are entirely lacking, with the
only exception being PRO which is successfully applied in the clinic
[20]. Despite the use of PRO and derivatives in the photodynamic
treatment of skin cancer [21,22], in vitro comet data and evidence
on pro-apoptotic, anti-carcinogenic and anti-proliferative effects of
PRO in different cell culture models are rare [22–26]. Also the DNA-
damaging effects of BR in cancer cells have been investigated only
once [27], when applying the single cell gel electrophoresis (SCGE/
comet) assay.
Stress stimuli such as DNA-damage provoke cellular
responses including oxidative stress, cell cycle arrest and
apoptosis, which is mainly controlled by the action of
tumor suppressors [21,22,26,28]. Many chemotherapeutics
including purine and pyrimidine analogs as well as alkylating
agents induce DNA-damage within rapidly proliferating cells
in an attempt to selectively target malignant cells. To assess
whether TPs exert comparable effects on cancer cell lines (e.g.
induce free radical formation), ﬁve essentially untested TPs
(BR-/BV-dimethyl ester (BR-/BV-DME), UB, SB, PRO) were
investigated together with BR, BRDT and BV in human color-
ectal adenocarcinoma (Caco2) and hepatocellular carcinoma
(HepG2) cells. These cell lines represent meaningful models
for TP in vitro testing, since both the liver and intestine
represent central organs for BP metabolism [29]. To elucidate
cellular regulatory mechanisms in response to TP exposure,
ﬂow cytometry analyses (apoptosis/necrosis, intracellular
radical species (ROS), cell cycle) were conducted to reveal
underlying mechanisms of TPs action, relevant to cancer cell
biology [21,22,26,28,30], while the comet assay was applied
to determine the extent of DNA damage.Materials and methods:
Chemicals
Unconjugated bilirubin IXa (BR) [CAS# 635–65–4], bilirubin
conjugate (ditaurate; disodium; BRDT) [CAS# 635–65–4],
biliverdin IXa (BV) [CAS# 55482–27–4], bilirubin dimethyl ester
(BR-DME) [CAS# 19792–68–8], biliverdin dimethyl ester (BV-
DME) [CAS# 10035–62–8], protoporphyrin IX (PRO) [CAS#
553–12–8] as well as urobilin (UB) [CAS# 28925–89–5] and
stercobilin (SB) [CAS# 34217–90–8] were purchased from Fron-
tier Scientiﬁc, UK, and were dissolved in DMSO. Solubility was
tested spectrophotometrically and purity via HPLC [15,31].
DMSO ﬁnal concentrations in media did not exceed 0.1%. Test
compounds were stored in airtight and lightproof containers at
80 1C until use, and were protected from light throughout all
test procedures using foil-covered containers. Other chemicals
were purchased from Sigma Aldrich, Austria (unless otherwise
noted), were of the highest analytical grade available and were
stored and used according to instructions.
Single cell gel electrophoresis assay
The comet assay measures DNA single- and double-strand breaks
in eukaryotic cells embedded in 1% low melting agarose (LMA;
Invitrogen Austria), ﬁxed on agarose pre-coated microscope
slides (1% normal melting agarose, NMA; Invitrogen Austria).
After cell lysis at pH 10 and 20 min of DNA unwinding (as well as
300 mM tertiary-butyl hydroperoxide (tert-BOOH) treatment for
positive controls), cells were exposed to a directed electric ﬁeld
(Electrophoresis CSL-10M40, Biozym Austria; pH 413). After
ethidium bromide staining (20 ml of 20 mg/ml/gel), DNA migra-
tion/comet formation was evaluated using a ﬂuorescent micro-
scope (Zeiss Germany) equipped with a camera (Hitachi Austria).
Komet 5.5. software (Andor Technology, GB) assessed comet tail
DNA content which was expressed as a percentage of total
cellular DNA (% tail DNA). The method of Azqueta et al. [32]
was used to measure both DNA single- and double-strand breaks.
Human lymphocytes were replaced by cancer cells, using 1106
cells/ml. Eight gels (two per slide; per compound and concentra-
tion) were prepared for statistical and quality assurance analysis,
six gels of which at minimum were randomly counted (50 cells/
gel).
Human Cancer cell lines
Cytotoxicity was assessed in two cell lines (Caco2 and HepG2)
that were originally derived from primary human tumors as
reported by the provider (source as below). Cell viability and cell
counts were assessed using a trypan blue assay-based automated
cell counter (Countess; Invitrogen, Austria).
Cell culture media. Cells were obtained from the German
Collection of Microorganisms and Cell Cultures (Leibniz Institute,
DSMZ), and were maintained using standard culture techniques.
Caco2 cells were cultivated in antibiotic-free Dulbecco’s modiﬁed
essential medium (DMEM with high glucose; PAA Austria), and
HepG2 cells in Eagle’s minimum essential medium with Earle’s
salts (MEM; PAA Austria) in sterile 25 cm2 ﬁlter cap ﬂasks (SPL
Life Sciences Inc., Austria). Media were supplemented with 10%
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amino acids, 1 ml of Na-pyruvate (HepG2) or 20% FBS (v/v) and
1 ml of 100 mM Na-pyruvate (Caco2). Experiments were con-
ducted between passages 17–37 for Caco2, and 34–54 for HepG2
cells. Media were changed every second day and on the days
before and after cell splitting, which was performed at 70–80%
conﬂuence, using 1 ml per ﬂask of Accutase solution (PAA
Austria). For TP incubation, 4.5105 cells/ml were seeded in
sterile 24 well plates (SPL Life Sciences Inc., Austria) and were
allowed to adhere for 24 h. All cultures were maintained at 37 1C
in a humidiﬁed atmosphere of 95% air, 5% CO2.
Flow cytometric analyses
After 24 h of TP incubation, cells were harvested from 24 well
plates and transferred to 5 ml FACS tubes (BD Biosciences,
Austria). After treatment including centrifugation, washing and
staining steps, cell suspensions were analyzed using a BD
FACSCalibur ﬂow cytometer (BD Biosciences, Austria).
Apoptosis/necrosis assay
The applied detection kit (r-phycoerythrin (PE) annexin V
apoptosis detection kit I, BD Pharmingen Austria) was used to
measure apoptosis and necrosis via ﬂow cytometry. This assay
requires the Ca2þ-dependent afﬁnity of annexin V to phosphatidyl
serine as well as the speciﬁcity of 7-aminoactinomycin-d (7-AAD)
for guanine–cytosine DNA-base pairs for the assessment of
apoptosis and necrosis. Brieﬂy, 1106 cells/ml were washed in
Ca2þ/Mg2þ-free 1 phosphate buffered saline (PBS; PAA Austria)
and re-suspended in binding buffer, were doubly labeled with
PE-stained annexin V (exmax: 496, emmax: 575 nm; FL-2), and
7-AAD (exmax: 546, emmax: 647 nm; FL-3) and were incubated for
15 min in the dark prior to cytometric analyses [33,34].
Intracellular radical species
To detect intracellular reactive oxygen species (ROS), 10 mM ﬁnal
concentration dihydroethidium (DHE) and 25 mM ﬁnal concen-
tration dihydroﬂuorescein diacetate (DCFH-DA), both in DMSO,
were added individually to incubated cells. Dihydroethidium is
cell-permeable and reacts with O2
-. to form oxyethidium. This
product interacts with nucleic acids and emits red ﬂuorescence,
which can be measured cytometrically (exmax: 329, emmax:
373 nm; FL-2) [35]. When DCFH-DA enters the cell, it is
cleaved by intracellular esterases to form DCFH, which is then
non-speciﬁcally oxidized by (hydro)peroxides to ﬂuorescent
70-dichlorodihydroﬂuorescein (DCF) (exmax: 498, emmax:
522 nm; FL-1) [35]. After washing in Ca2þ/Mg2þ-free 1PBS and
prior to measurement, 1106 cells/ml were stained with DHE (in
FACS tubes after harvesting) or with DCFH (in 24 wells prior to
harvesting) and were left to incubate for 20 min in the dark [36].
Cell cycle assay
The cell cycle assay measures the percentage number of cells in
the cell cycle phases G0/1, S, G2/M, as well as apoptotic cells (sub
G0/1), according to ﬂuorescence intensity, based on the number
of DNA copies within cells. Propidium iodide (PI; exmax: 535,
emmax: 617 nm; FL-2) binds to DNA by intercalating between the
bases with a stoichiometry of one PI molecule per 4.5 DNA base
pairs. After washing, 1106 cells/ml were ﬁxed with 75% ice-
cold absolute ethanol and were left to incubate for 30 min on ice.Cells were re-suspended in 500 ml of phosphate buffer (96 ml
0.2 M Na2HPO4þ4 ml 0.1 M C6H8O7), and after centrifugation,
50 mM of 100 mg/ml RNase and 200 ml of 50 mg/ml PI (both in
dH2O) were added [37,38]. Cell suspensions were measured
immediately.
Statistical analyses
To evaluate DNA-damaging effects of TPs in the comet assay,
50 cells/gel were counted. As a measure of DNA-damage, mean
percentages of total DNA (% tail DNA) were calculated in
Microsoft Excel. Statistical analysis was completed using IBM
SPSS 19 for Windows. Normal distribution of the data was
assessed using the K–S test. To calculate differences in DNA-
damage between groups, ANOVA was performed on parametric
data and Kruskal–Wallis H-test on non-parametric data, followed
by the Dunnett-T3 post-hoc test, assuming non-homogeneous
variances. Pearson bivariate correlations were performed on
parametric data, and Spearman rho on non-parametric data. A
p-value r0.05 was considered signiﬁcant.
Free BR concentrations (BRf) were calculated as published
earlier [39], by using the Microsoft Excel’s Solver function.Results
DNA-damage/comet formation in Caco2 and HepG2 cell
lines:
Protoporphyrin, urobilin, stercobilin
In both cell lines, PRO at the highest and lowest tested concen-
trations induced signiﬁcant DNA-damage versus negative control
(po0.05), as was the case in HepG2 cells, also in comparison to
positive control (po0.05; Figs. 1 and 2A). Following UB incuba-
tion in both cell lines, DNA-damaging effects tended to be or
were signiﬁcantly increased compared to negative control
(po0.05; Figs. 1 and 2B). In HepG2 cells, SB elevated DNA-
damage compared to negative and positive controls (po0.05;
Fig. 2C).
Bilirubin, bilirubin ditaurate, and bilirubin dimethyl ester
In Caco2 cells, the highest tested BR concentration led to
signiﬁcantly reduced comet formation compared to negative
control (po0.05; Table 1). Somewhat in contrast, conjugated
BRDT at 0.5 mM showed signiﬁcantly elevated DNA-damage
versus negative control in Caco2 cells (po0.05; Table 1).
In HepG2 cells, however, BRDT did not induce DNA-damage
compared to negative or positive control (po0.05; Table 1).
Bilirubin dimethyl ester incubation with Caco2 and HepG2 cells
showed no DNA-damaging effects.
Biliverdin, biliverdin dimethyl ester
In Caco2 cells, BV and BV-DME did not signiﬁcantly increase
DNA-damage versus negative control (po0.05; Table 1). How-
ever, BV incubation in HepG2 cells caused signiﬁcantly elevated
DNA-damage at all tested concentrations compared to the
negative control (po0.05; Table 1). Also BV-DME at the lowest
and highest tested concentrations led to signiﬁcantly elevated
DNA-damage compared to negative control (po0.05; Table 1).
Fig. 1 – DNA-damaging effects of (A) protoporphyrin, (B) urobilin and (C) stercobilin in Caco2 cells. nn: signiﬁcantly different to
negative control (pr0.05), np: signiﬁcantly different to positive control (pr0.05).
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Fig. 2 – DNA-damaging effects of (A) protoporphyrin, (B) urobilin and (C) stercobilin in HepG2 cells. nn: signiﬁcantly different to
negative control, np: signiﬁcantly different to positive control, #n: not signiﬁcantly different to negative control, however strong
trend (pr0.1).
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Table 1 – Mean % tail DNA in Caco2 and HepG2 cells (7 SD) after 24 h TP incubations, compared to positive and negative
controls.
Caco2
Tetrapyrrole (mM) % tail DNA7SD % tail DNA pos control7SD % tail DNA neg control7SD
BR 0.5 18.773p 36.574 21.373
BR 5 21.373.8p
BR 17 13.871.9np
BRDT 0.5 10.872.6np 29.172.7 7.772.0
BRDT 5 11.772.6p
BRDT 17 18.274.1p
BR-DME 0.5 8.772.7 21.973.9 9.974.0
BR-DME 5 11.572.3p
BR-DME 17 15.076.9p
BV 0.5 20.974.3p 30.175.0 16.572.6
BV 5 20.872
BV 17 18.472.7
BV-DME 0.5 15.673.5p 26.672.9 15.572.5
BV-DME 5 15.373.2p
BV-DME 17 12.972.2p
HepG2
Tetrapyrrole % tail DNA7SD % tail DNA pos control7SD % tail DNA neg control7SD
BR 0.5 10.872.8 18.573.9 9.371.0
BR 5 9.272.9
BR 17 9.771.3
BRDT 0.5 8.270.8p 13.370.9 7.472.0
BRDT 5 8.871.4p
BRDT 17 8.571.1p
BR-DME 0.5 8.872.5p 13.472.5 6.872.3
BR-DME 5 9.371.3p
BR-DME 17 8.772.5
BV 0.5 17.271.4n 16.870.7 12.371.0
BV 5 15.170.9np
BV 17 16.671.3n
BV-DME 0.5 17.072.2np 21.672.1 12.371.6
BV-DME 5 14.672.0p
BV-DME 17 17.871.4np
BR: unconjugated bilirubin, BRDT: bilirubin ditaurate, BV: biliverdin, BV-DME: biliverdin dimethyl ester, TP: tetrapyrrole.
p: signiﬁcantly different to positive control (pr0.05).
n: signiﬁcantly different to negative control (pr0.05).
np: signiﬁcantly different to negative and positive controls (pr0.05).
E X P E R I M E N T A L C E L L R E S E A R C H 3 1 9 ( 2 0 1 3 ) 5 3 6 – 5 4 5 541Correlations between DNA-damage/comet formation and
ﬂow cytometry parameters:
Protoporphyrin, urobilin, and stercobilin
In HepG2 cells, a positive relationship between PRO-induced
comet formation and intracellular ROS (superoxide) production
was determined (po0.05; Table 2).Superoxide formation after
PRO incubation in HepG2 cells was positively correlated to
apoptosis (r 0.529, po0.05).Bilirubin, bilirubin ditaurate, and bilirubin dimethyl ester
For BR, a positive correlation was determined between comet
and intracellular ROS formations (superoxide and hydroperox-
ide) in both Caco2 and HepG2 cell lines (po0.05; Table 2). ROS
(superoxide) formation in HepG2 cells after BR incubation was
positively related to apoptosis (r 0.704, po0.01).Biliverdin, biliverdin dimethyl ester
Following BV incubation in Caco2 cells a positive correlation was
determined between DNA-damaging effects and ROS formation
(Table 2). In HepG2 cells BV-DME-based comet formation sig-
niﬁcantly correlated with apoptosis (po0.05; Table 2). In HepG2
cells ROS formation after BV incubation non-signiﬁcantly corre-
lated with apoptosis (r 0.488, p 0.077).Discussion
In this study, a range of physiologically abundant TPs (BR, BRDT,
BV, UB, SB, PRO) were investigated with non-physiological BR-
and BV-DME, to test their effects on ROS accumulation, DNA-
damage (comet formation) and apoptosis in HepG2 and Caco2
cell lines. Most of the investigated TPs were found to induce
DNA-damage in Caco2 and HepG2 cells, and effects appeared to
be most pronounced with intestinal TPs (SB, UB, PRO; Figs. 1 and
Table 2 – Correlations (r) of comet tail DNA percentages (% tail DNA) and ﬂow cytometry parameters (cell death, ROS
formation) in Caco2 and HepG2 cells.
Caco2 DNA damage (% tail DNA)
BR BRDT BR-DME BV BV-DME SB PRO
Necrosis 0.726 p¼0.011
Hydroperoxide 0.727 p¼0.011 0.904 p¼0.001
HepG2 DNA damage (% tail DNA)
BR BRDT BV-DME UB SB PRO
Apoptosis 0.644 p¼0.010
Superoxide 0.547 p¼0.053# 0.583 p¼0.036
BR: unconjugated bilirubin, BRDT: bilirubin ditaurate, BR-DME: bilirubin dimethyl ester, BV: biliverdin, BV-DME: biliverdin dimethyl ester, UB:
urobilin, SB: stercobilin, PRO: protoporphyrin.#non-signiﬁcant trend.
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viability; not shown) showed no signiﬁcant differences between
the tested TP concentrations and negative controls. Therefore,it
can be concluded that comet formation was not due to acute
cytotoxic effects, but was predicated by mild TP-induced DNA
damage. This was conﬁrmed in both cell lines by elevated levels
of apoptosis after BR, PRO and SB incubations (Supplementary
material 2; Figs. 3 and 4A–C), as well as by the lack of positive
correlation between DNA-damage and necrosis (Table 2). These
data suggest that intestinal BPs induce non-acute toxicity in
malignant hepatic and intestinal cancer cells in vitro.
Single- and double-strand DNA breaks represent critical
damage to healthy cells [30]. Whilst mild impairment can yet
activate innate repair mechanisms, severe nucleotide breaks can
trigger cell death including apoptosis and/or tumorigenesis
[40,41], the latter resulting from genetic ampliﬁcation or
translocation processes leading to oncogene activation [30].
In contrast, radiation [42] and chemotherapeutic treatment can
overwhelm cellular repair systems by inducing the production of
ROS, which attack and fragment cancer cell DNA, and can cause
apoptosis in tumor cells [43]. Cell survival after imperfect repair
of DNA-damage on the other hand, can lead to carcinogenesis
through mutations, and the formation of many tumors has been
associated with the inhibition of apoptosis [44,45].
Bile pigments (particularly BR) are known for their antioxidant
activity at low to moderate concentrations; however, they can
possess pro-oxidant activity at high concentrations [6,46].
Furthermore it is important to note that the ratio of BR to
albumin represents an important determinant of ‘free’ BR [47].
This concentration inﬂuences the degree to which unbound BR
can diffuse into cells [48] and interact with the mitochondrial
membrane, where it may induce depolarization leading to
apoptosis [17]. The average fecal BR concentration is estimated
at 42 mM, a considerable proportion of which however is assu-
mingly unavailable for cellular absorption due to binding and
precipitation [17]. It is currently unknown whether also related
TPs interact with albumin and how they interact with cells
within the human organism. Clearly, further pharmacokinetic
and bio-distribution studies are required to reveal the in vivo fate
and consequences of these molecules [15,16].
In the present study, BR provoked intracellular ROS accumula-
tion (Table 2). This result had been observed previously [27], andBR’s anti-cancer behavior had been discussed with reference to a
pro-oxidant effect. Particularly with regard to BR, observed toxic
or pro-oxidant effects in HepG2 cells seen in the present study
(Table 2; online Supplementary material 2) can probably be
explained by a relatively higher ‘‘free’’ BR concentration in the
cell culture media administered to HepG2 cells (10% FBS addi-
tion), compared to the higher albumin binding capacity present
in Caco2 cell media (20% FBS addition). It is likely that the mildly
elevated ‘‘free’’ bilirubin concentration resulted in BR absorption
[48]into the mitochondrial membrane, leading to mitochondrial
dysfunction and increased superoxide and hydrogen peroxide
production, by interfering with mitochondrial cytochrome func-
tion [49]. At a BR concentration of 17 mM, calculated BRf levels in
both cell lines (10% and 20% FBS addition; data not shown) clearly
exceeded 70 nM (by orders of 2.3–60). Concentrations above this
are associated with the induction of apoptosis [39]. Therefore, we
hypothesize that BR, despite its known antioxidant potential,
cannot neutralize increased production of reactive oxygen species,
during mitochondrial depolarization/dysfunction.
As initially stated, DNA-damage is frequently associated with
increased ROS production. With relevance to ROS-induced
effects, correlations between DNA-damage and ROS formation
(superoxide) were found in PRO and BR conditions in HepG2, as
well as in BV and BR conditions in Caco2 cells (hydroperoxide).
This emphasizes the compounds’ potential role in causing ROS-
mediated cell death in cancer cells. Elevated oxidative stress after
PRO administration in rat hepatocytes had also been reported
earlier, in which elevated superoxide formation had been
assumed based upon an elevated superoxide dismutase (SOD)
activity [50]. Elevated superoxide radical formation has also been
detected in vitro after PRO administration using spin trapping
techniques [51].
With the remaining TPs (BRDT, UB, SB, and BR-/BV-DME)
no relationships with ROS formation were found in this study.
These data suggest that these compounds either induced
DNA-damage directly by interfering with DNA or associated
molecules, or that radical species other than those measured,
account for the observed DNA-damage. In some cases (PRO and
BR in HepG2 cells), ROS formation was correlated to apoptosis,
which supports a role for the induction of oxidation by certain
BPs, leading to cancer cell death via activation of apoptotic
pathways.
Fig. 3 – Effects of 24 h PRO (A), UB (B) and SB (C) incubation in
Caco2 cells, on cell cycle progression (PI-staining). PRO:
protoporphyrin, UB: urobilin, SB: stercobilin; nn: signiﬁcantly
different to negative control (pr0.05), #n: tends to differ from
negative control (pr0.1).
Fig. 4 – Effects of 24 h PRO (A), UB (B) and SB (C) incubation in
HepG2 cells, on cell cycle progression (PI-staining). PRO:
protoporphyrin, UB: urobilin, SB: stercobilin; nn: signiﬁcantly
different to negative control (pr0.05), #n: tends to differ from
negative control (pr0.1).
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G0/1; Figs. 3 and 4A–C) provides further important data for
mechanistically explaining cytotoxic results reported in the
comet assay. Comet formation in both cell lines, and speciﬁcally
in HepG2 cells after SB, UB and PRO incubations (Figs. 1 and
2A–C) are supported by an accumulation of cells in G0/1 phase
and an increase in apoptosis, measured using annexin V-staining
(Figs. 3 and 4A–C). This conclusion is particularly evident for SB-
induced DNA-damage, which is supported by increased percen-
tage of cells in G0/1 and sub G0/1 (apoptosis) phases. With
reference to these data, SB had the strongest effects on G0/1 cell
cycle accumulation and apoptosis in both cell lines. In general, SBand PRO-induced more pronounced effects especially in Caco2
cells, whereas UB’s effects on apoptosis were comparatively mild
(Fig. 3A–C).
In summary, the current results indicate that BPs such as PRO,
BR and BV induce radical formation that is related to DNA-
damage, which was associated with increased apoptosis (PRO,
BR). Since correlations with ROS formation (superoxide and
hydroperoxide) were not found in all test conditions, it is also
possible that other radical species had been formed such as
carbon/nitrogen-centered radicals, which were not detected by
the assays utilized in this study. Generally speaking, DNA-
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which agrees with a possible mechanism of DNA damage
proposed by Goodsell [43]. In this model, reactive forms of
oxygen attack and differently fragment cancer cell DNA involving
single- and double-strand breaks, and lead to cell death via cell
cycle arrest and subsequent apoptosis induction.
In normally proliferating lymphocyte cultures, used as a model
of healthy human tissue, no increased micronuclei [13] and
comet formations (submitted elsewhere) in the presence of
mildly elevated circulating BR have been found recently by our
work-group. These data further support the possibility of toxicity
and DNA-damaging effects of BPs/derivatives speciﬁcally in
cancer cells, and emphasize the role moderately elevated BR
levels play in (gastrointestinal) carcinogenesis, as was reported
in a representative epidemiological US study [14]. A 1 mg/dl
increment in serum BR was associated with a reduced lifetime
prevalence of gastrointestinal and colorectal cancer, with odds
ratios of 0.186 in women and 0.295 in men [14].Conclusions
Bile pigments with structurally related TPs are reported to
possess anti-mutagenic and antioxidant effects in vitro, and to
be of physiological importance by inhibiting oxidative stress
in vivo and thereby preventing chronic disease [9]. However, data
concerning the potential toxic effects of these compounds in
cancer cells (beyond BR and PRO) are lacking. This study revealed
substantial DNA-damaging effects of tetrapyrrolic compounds in
human cancer cells, particularly for PRO, UB and SB in HepG2 and
for PRO in Caco2 cell lines. From this evidence, a chemopreventive
effect of the compounds might exist within the liver and intestine,
as has been suggested in epidemiological studies [14,52,53].
Possible underlying mechanisms of DNA-damage (e.g. including
ROS formation), leading to cell cycle arrest and subsequent
apoptosis induction, might be responsible for the toxicity observed
in malignant cells.
Subsequent future experiments could focus on clarifying the
effects of TPs also in non-malignant cells as well as the pigments’
DNA-damaging potential in a range of various other cancer cell
lines. Furthermore, exploring the effects of TPs also on chromo-
somal stability (e.g. prevention of micronuclei formation) could
represent a valuable future scientiﬁc approach.Declaration of interest
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